Redburn Atlantic initiated coverage on Alnylam Pharma with a new price target

3/31/25 8:12:33 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Redburn Atlantic initiated coverage of Alnylam Pharma with a rating of Buy and set a new price target of $353.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ALNY

Date	Price Target	Rating	Analyst
3/31/2025	$353.00	Buy	Redburn Atlantic
3/24/2025	$280.00 → $328.00	Neutral → Overweight	Analyst
11/12/2024		Peer Perform → Underperform	Wolfe Research
10/16/2024		Sector Outperform	Scotiabank
8/16/2024	$198.00 → $370.00	Neutral → Buy	Goldman
2/16/2024	$173.00	Buy → Neutral	Goldman
2/15/2024		Peer Perform	Wolfe Research
12/8/2023	$171.00	Equal Weight	Wells Fargo